Stock Market & Financial News
IMAX seen poised for stronger second half despite expected modest Q2
IMAX Corp (NYSE:IMAX) is positioned for a stronger second half of 2026 despite expectations for modest second quarter growth, according to Wedbush, which reiterated its ‘Outperform' rating and $46 price target ahead of the company's earnings report. Shares of IMAX traded hands at $38 on Friday morning, up about 5% so far this year.
IMAX Husqvarna AB (publ) (HSQVY) Q2 2026 Earnings Call Transcript
Husqvarna AB (publ) (HSQVY) Q2 2026 Earnings Call Transcript
HSQVY ASSA ABLOY AB (publ) (ASAZY) Q2 2026 Earnings Call Transcript
ASSA ABLOY AB (publ) (ASAZY) Q2 2026 Earnings Call Transcript
ASAZY South Plains Financial, Inc. (SPFI) Q2 2026 Earnings Call Transcript
South Plains Financial, Inc. (SPFI) Q2 2026 Earnings Call Transcript
SPFI 
TFC Q2 Earnings Beat on Lower Provisions, Stock Dips on NIM Concern
Truist's Q2 earnings beat estimates as higher NII and fee income, loan growth and lower provisions offset rising expenses and margin pressure.
TFC 
CVX vs. TTE: Which Energy Giant Deserves a Place in Your Portfolio?
Chevron's premium assets, strong balance sheet and steadier earnings outlook give it a slight edge over TotalEnergies for long-term investors.
CVX 
3 Medical Instrument Stocks Betting on GenAI to Ease Industry Hurdles
GenAI creates new opportunities for ISRG, ALC and LIVN, even as regulatory, inflation and industry headwinds continue to pressure MedTech.
ALC 
MAN's Q2 Earnings & Revenues Surpass Estimates, Increase Y/Y
ManpowerGroup beats Q2 earnings and revenue estimates as broad regional growth, cost discipline and stronger demand support results and its Q3 outlook.
MAN 
Esquire Financial (ESQ) Soars 5.2%: Is Further Upside Left in the Stock?
Esquire Financial (ESQ) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
ESQ 
Alphabet Drops 4%, But Analyst Believes There Is Massive Upside
Alphabet shares currently trade at $354.46 while Wall Street's consensus analyst price target sits at $431.72, a gap of roughly 21.8% between current price and fair value.
GOOG 
Investors Push $79M Into Bitcoin ETFs as Ether Funds Lose $28M
Crypto ETF demand split sharply on Thursday, July 16, as bitcoin products drew $79.15 million while ether funds lost $28.04 million. XRP and Solana ETFs also attracted fresh capital, while T. Rowe Price launched a multi-token fund with an unusually large HYPE allocation.
Can BWXT's Manufacturing Investments Support Future Growth?
BWX Technologies expands manufacturing investments to strengthen production capacity across defense, commercial nuclear and advanced reactor markets.
BWXT 
GSK Discontinues Development of Camlipixant for Refractory Chronic Cough
GSK drops camlipixant's refractory chronic cough program after mixed phase III results, but the drug remains in a phase IIb study for irritable bowel syndrome.
GSK 
TXN Likely to Beat Q2 Earnings Estimates: How to Play the Stock?
Texas Instruments is poised for a Q2 earnings beat as analog and embedded chip demand rises, led by industrial, data center and automotive strength.
TXN 
Is SpaceX stock warming up to become the next meme stock?
SpaceX (SPCX) stock is tumbling further this morning after the firm's 13th Starship test flight was aborted right before liftoff as several engines failed to start properly. The development adds fuel to the bearish fire that has already assembled a $25 billion wall against billionaire Elon Musk's space infrastructure and artificial intelligence (AI) behemoth.
SPCX 
Morgan Stanley unlocks Bitcoin, Ethereum and Solana on E*TRADE
Morgan Stanley has completed the rollout of Bitcoin, Ethereum, and Solana trading on E*TRADE, charging eligible clients a 0.50% fee on each transaction.
Truecaller AB (publ) (TRUBF) Q2 2026 Earnings Call Transcript
Truecaller AB (publ) (TRUBF) Q2 2026 Earnings Call Transcript
TRUBF 
Alleima AB (publ) (SAMHF) Q2 2026 Earnings Call Transcript
Alleima AB (publ) (SAMHF) Q2 2026 Earnings Call Transcript
SAMHF 
Japanese Yen Short-term Outlook: USD/JPY Defends the Uptrend as the Range Tightens
USD/JPY USD/JPY closes week at an increasingly important technical juncture after spending the past three weeks consolidating within the July opening range. The pullback from the monthly highs found support at a key confluence zone, preserving the broader uptrend while allowing the pair to work off overextended conditions.
Meta's Agentic AI Leadership Strategy is Why I Can't Stop Buying Over and Over
I keep buying Meta Platforms (NASDAQ:META | META Price Prediction), and I am not planning to stop.
META 
Best Momentum Stocks to Buy for July 17th
JBTH, TSM and JPM made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 17, 2026.
JBHT 
Strategy CEO Says Bitcoin Must Crash to $10,000 Before Debt Risks Become a Concern
Strategy CEO Phong Le has sought to reassure investors that the company's balance sheet remains resilient despite Bitcoin's latest downturn.
Sweetgreen Stock Soars as Diners Take a Sigh of Relief Over Cyclospora Outbreak
Other food and restaurant stocks jumped, too, as investors likely hope that customers will resume their normal food-shopping habits.
SG 
Apple races past Nvidia to reclaim crown as world's most valuable company
Apple is reclaiming the top spot for the first time since April last year.
AAPL 
QuantumScape: Eagle Line Pilot Production Success Story
QuantumScape is rated a buy due to its strong execution on the Eagle Line pilot, signaling near-term commercialization potential. QS's Cobra process now achieves heat treatment speeds 25x faster, supporting scalable battery production and competitive energy densities up to 850 Wh/L. Customer billings are accelerating, with FY2026 annualized projections of $44 million, indicating robust B1 sample acceptance and readiness for automotive commercialization.
QS 
Novo Nordisk: The Oral Wegovy Promise
Novo Nordisk has made robust gains of 40% at the stock markets since April, supported by the success of oral Wegovy and attractive valuations. The Wegovy pill can see a nice revenue uptick in Q2 2026 going by recent data, and that can continue into the year as it gains approvals from international markets. Importantly, the pill has made gains even when competitor Eli Lilly's Foundayo has seen limited success, which can give Novo Nordisk a much-needed boost.
NVO 
Regions Financial Q2 Earnings Beat Estimates, NII, Expenses Up Y/Y
RF tops Q2 earnings estimates as NII and improving credit quality offset expense growth, but revenues fall short of expectations.
RF 
Packaging Corp Gears Up for Q2 Earnings: What to Expect?
PKG is set to post Q2 results on July 22, with revenues rising 10.7% as the Greif acquisition is expected to support earnings despite lower EPS estimates.
PKG 
AGNC Investment to Report Q2 Earnings: What's in Store for the Stock?
AGNC set to report Q2'26 earnings on July 20 as investors watch net interest income, asset yields and book value amid mortgage-rate volatility.
AGNC 
Liberty Energy Q2 Earnings on Deck: Here's How It Will Fare
Liberty Energy Inc. LBRT is set to report second-quarter 2026 earnings on July 22, after the closing bell. The Zacks Consensus Estimate for earnings is pegged at 7 cents per share, and the same for revenues is pinned at $1.09 billion.
LBRT 
